IndraLab

Statements

USP9X activates TP53. 2 / 2

| 1 1

reach

"In addition, we explored the underlying mechanisms of the combined therapy, and showed that usp9x inhibition by WP1130 promoted the degradation of p53 in doxorubicin-treated HCC cells.Human liver canc[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

25749422

➶

sparser

"FAM188B silencing activates p53 and its downstream pathway."

29795372

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP9X activates TP53. 2 / 2

INDRA sources:

Databases

Reading